What's in SPP Pharmaclon Ltd.'s pipeline?

SPP Pharmaclon Ltd. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with SPP Pharmaclon Ltd.'s portfolio?

Top competitors by shared drug class: Bayer Healthcare Pharms, Chiron, Guna spa, University of British Columbia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/spp-pharmaclon-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

SPP Pharmaclon Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SPP Pharmaclon Ltd. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Interferon-Gamma	Interferon-Gamma	marketed	Lymphocyte Growth Factor [EPC]

Therapeutic area mix

No therapeutic area data.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer Healthcare Pharms · 1 shared drug class
Chiron · 1 shared drug class
Guna spa · 1 shared drug class
University of British Columbia · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for SPP Pharmaclon Ltd.:

Cite this brief

Drug Landscape (2026). SPP Pharmaclon Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/spp-pharmaclon-ltd. Accessed 2026-06-10.